Connection

Michael Ullian to Animals

This is a "connection" page, showing publications Michael Ullian has written about Animals.
Connection Strength

0.426
  1. Angiotensin II receptors and peritoneal dialysis-induced peritoneal fibrosis. Int J Biochem Cell Biol. 2016 08; 77(Pt B):240-50.
    View in: PubMed
    Score: 0.039
  2. Clathrin-dependent internalization of the angiotensin II AT1A receptor links receptor internalization to COX-2 protein expression in rat aortic vascular smooth muscle cells. Eur J Pharmacol. 2015 Feb 05; 748:143-8.
    View in: PubMed
    Score: 0.035
  3. Angiotensin II activates NF-?B through AT1A receptor recruitment of ?-arrestin in cultured rat vascular smooth muscle cells. Am J Physiol Cell Physiol. 2013 Jun 15; 304(12):C1176-86.
    View in: PubMed
    Score: 0.032
  4. Angiotensin II-induced cyclooxygenase 2 expression in rat aorta vascular smooth muscle cells does not require heterotrimeric G protein activation. J Pharmacol Exp Ther. 2009 Jul; 330(1):118-24.
    View in: PubMed
    Score: 0.024
  5. Thiol antioxidants regulate angiotensin II AT1 and arginine vasopressin V1 receptor functions differently in vascular smooth muscle cells. Am J Hypertens. 2009 Feb; 22(2):221-7.
    View in: PubMed
    Score: 0.023
  6. COX-2 expression stimulated by Angiotensin II depends upon AT1 receptor internalization in vascular smooth muscle cells. Biochim Biophys Acta. 2008 Jun; 1783(6):1048-54.
    View in: PubMed
    Score: 0.022
  7. N-acetylcysteine decreases angiotensin II receptor binding in vascular smooth muscle cells. J Am Soc Nephrol. 2005 Aug; 16(8):2346-53.
    View in: PubMed
    Score: 0.018
  8. Mechanisms of vascular angiotensin II surface receptor regulation by epidermal growth factor. J Cell Physiol. 2004 Sep; 200(3):451-7.
    View in: PubMed
    Score: 0.017
  9. Potential importance of glomerular citrate synthase activity in remnant nephropathy. Kidney Int. 2003 Jan; 63(1):156-64.
    View in: PubMed
    Score: 0.015
  10. Role of citrate synthase in aldosterone-mediated sodium reabsorption. Hypertension. 2000 Apr; 35(4):875-9.
    View in: PubMed
    Score: 0.013
  11. Resistance to remnant nephropathy in the Wistar-Furth rat. J Am Soc Nephrol. 1999 Apr; 10(4):814-21.
    View in: PubMed
    Score: 0.012
  12. The role of corticosteriods in the regulation of vascular tone. Cardiovasc Res. 1999 Jan; 41(1):55-64.
    View in: PubMed
    Score: 0.012
  13. The Wistar-Furth rat as a model of mineralocorticoid resistance. Kidney Int Suppl. 1997 Oct; 61:S10-3.
    View in: PubMed
    Score: 0.011
  14. Regulation of vascular angiotensin II receptors by EGF. Am J Physiol. 1997 10; 273(4):C1241-9.
    View in: PubMed
    Score: 0.011
  15. Resistance to mineralocorticoids in Wistar-Furth rats. Am J Physiol. 1997 Mar; 272(3 Pt 2):H1454-61.
    View in: PubMed
    Score: 0.010
  16. Potentiation of angiotensin II action by corticosteroids in vascular tissue. Cardiovasc Res. 1996 Aug; 32(2):266-73.
    View in: PubMed
    Score: 0.010
  17. Carbenoxolone damages endothelium and enhances vasoconstrictor action in aortic rings. Hypertension. 1996 Jun; 27(6):1346-52.
    View in: PubMed
    Score: 0.010
  18. Corticosterone metabolism and effects on angiotensin II receptors in vascular smooth muscle. Circ Res. 1995 Oct; 77(4):702-9.
    View in: PubMed
    Score: 0.009
  19. Potentiation of angiotensin II-stimulated vascular contraction by lithium. Am J Physiol. 1995 May; 268(5 Pt 2):H2009-16.
    View in: PubMed
    Score: 0.009
  20. Mechanisms of enhanced angiotensin II-stimulated signal transduction in vascular smooth muscle by aldosterone. J Cell Physiol. 1994 Nov; 161(2):201-8.
    View in: PubMed
    Score: 0.009
  21. Angiotensin II-aldosterone interactions on protein synthesis in vascular smooth muscle cells. Am J Physiol. 1993 Jun; 264(6 Pt 1):C1525-31.
    View in: PubMed
    Score: 0.008
  22. Fatty acid inhibition of angiotensin II-stimulated inositol phosphates in smooth muscle cells. Am J Physiol. 1993 Feb; 264(2 Pt 2):H595-603.
    View in: PubMed
    Score: 0.008
  23. Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses. Hypertension. 1992 Jul; 20(1):67-73.
    View in: PubMed
    Score: 0.007
  24. K depletion alters angiotensin II receptor expression in vascular smooth muscle cells. Am J Physiol. 1990 May; 258(5 Pt 1):C849-54.
    View in: PubMed
    Score: 0.006
  25. Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells. J Clin Invest. 1989 Sep; 84(3):840-6.
    View in: PubMed
    Score: 0.006
  26. Hemodynamic effects of potassium. Semin Nephrol. 1987 Sep; 7(3):239-52.
    View in: PubMed
    Score: 0.005
  27. The missense mutation in Abcg5 gene in spontaneously hypertensive rats (SHR) segregates with phytosterolemia but not hypertension. BMC Genet. 2005 Jul 18; 6:40.
    View in: PubMed
    Score: 0.005
  28. Mitogen-induced rapid phosphorylation of serine 795 of the retinoblastoma gene product in vascular smooth muscle cells involves ERK activation. J Biol Chem. 2004 Jun 04; 279(23):24899-905.
    View in: PubMed
    Score: 0.004
  29. ERK is regulated by sodium-proton exchanger in rat aortic vascular smooth muscle cells. J Biol Chem. 2004 Jan 16; 279(3):1845-52.
    View in: PubMed
    Score: 0.004
  30. Mitogen-induced activation of Na+/H+ exchange in vascular smooth muscle cells involves janus kinase 2 and Ca2+/calmodulin. Biochemistry. 2003 Jun 17; 42(23):7178-87.
    View in: PubMed
    Score: 0.004
  31. Bradykinin B2 receptor activates extracellular signal-regulated protein kinase in mIMCD-3 cells via epidermal growth factor receptor transactivation. J Pharmacol Exp Ther. 2003 Mar; 304(3):968-77.
    View in: PubMed
    Score: 0.004
  32. A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. Am J Physiol Renal Physiol. 2000 Sep; 279(3):F440-8.
    View in: PubMed
    Score: 0.003
  33. Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am J Physiol. 1999 08; 277(2):C253-61.
    View in: PubMed
    Score: 0.003
  34. Expression, characterization, and purification of C-terminally hexahistidine-tagged thromboxane A2 receptors. J Biol Chem. 1998 Aug 28; 273(35):22753-60.
    View in: PubMed
    Score: 0.003
  35. Cloning and characterization of an endogenous COS-7 cell thromboxane A2 receptor. Biochim Biophys Acta. 1998 May 27; 1403(1):109-14.
    View in: PubMed
    Score: 0.003
  36. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension. 1995 Nov; 26(5):764-70.
    View in: PubMed
    Score: 0.002
  37. Sex steroid regulation of thromboxane A2 receptors in cultured rat aortic smooth muscle cells. Prostaglandins. 1995 Mar; 49(3):183-96.
    View in: PubMed
    Score: 0.002
  38. Effects of nifedipine and enalapril on glomerular injury in rats with deoxycorticosterone-salt hypertension. Am J Physiol. 1990 Oct; 259(4 Pt 2):F598-604.
    View in: PubMed
    Score: 0.002
  39. Angiotensin II surface receptor coupling to inositol trisphosphate formation in vascular smooth muscle cells. J Biol Chem. 1990 Jan 05; 265(1):195-200.
    View in: PubMed
    Score: 0.002
  40. Renal vascular effects of antihypertensive therapy in uninephrectomized SHR. Kidney Int. 1989 Mar; 35(3):790-8.
    View in: PubMed
    Score: 0.001
  41. Mechanism of the antihypertensive effect of K depletion in the spontaneously hypertensive rat. Kidney Int. 1988 Jul; 34(1):18-25.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.